Medical News

RSS

Researchers discover therapy for treating terminal stages of cancer

For the first time ever, researchers have discovered a therapy that can effectively treat the now invariably lethal, terminal stages of cancer in animals. The study appears in the latest issue of the Proceedings of the National Academy of Sciences.

5 Oct 2010

New bill aims to promote federal agency collaboration on foreign aid, national security

House lawmakers recently introduced the 2010 Interagency National Security Professional Education, Administration and Development System Act in an effort to promote better "collaboration among federal agencies supporting security missions and foreign aid operations overseas," Government Executive reports.

5 Oct 2010

$Osseon receives second patent NOA for spinal vertebral compression fracture technology$

Osseon receives second patent NOA for spinal vertebral compression fracture technology

Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, received its second patent Notice of Allowance (NOA) for its spinal vertebral compression fracture (VCF) technology.

5 Oct 2010

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 million to $1.5 million but denied Merck's request for judgment in its favor or a new trial in the case of Boles v. Merck, a retrial of a federal FOSAMAX case.

5 Oct 2010

Media examines PEPFAR hearing, calls for more HIV funding ahead of Global Fund replenishment meeting

Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.

5 Oct 2010

Human growth hormone can treat cystic fibrosis symptoms

Human growth hormone can be used successfully to treat some symptoms of cystic fibrosis, but its impact on the disease itself remains unknown, according to a new report funded by HHS' Agency for Healthcare Research and Quality (AHRQ).

5 Oct 2010

Researchers identify new type of cell that protects from immune system attack

Researchers at the Dana-Farber Cancer Institute in Boston have identified a new type of cell in mice that dampens the immune system and protects the animal's own cells from immune system attack.

5 Oct 2010

CrystalGenomics to present Phase I MAD study data at Arrowhead Summit

CrystalGenomics, Inc. and CG Pharmaceuticals, Inc. a drug discovery and development biopharmaceutical company, has announced that Dr. William Schmidt, its Vice President of Clinical Development, has been invited to present a talk on Development of CG100649, Tissue-selective Dual Inhibitor of COX-2 and Carbonic Anhydrase for Treatment of Osteoarthritis at Arrowhead's upcoming 4th Annual Pain Therapeutics Summit, to be held on October 4-5, 2010 in Philadelphia.

5 Oct 2010

African leaders to meet in Zambia to discuss country responses to HIV/AIDS

Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.

5 Oct 2010

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Neuro-Biotech Corporation introduces a Neuro-biomarker which is linked to a series of Neuro-Bio tests. This will permit to understand the science behind them and how they each will contribute to a progressive clinical investigation involving the input and output of the brain.

5 Oct 2010

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

New research from Rhode Island Hospital found that reduced levels of brain-derived neurotrophic factor (BDNF), a protein in the brain that encourages growth of neurons, may be a trait marker for individuals with psychogenic non-epileptic seizures (PNES) (seizures that are psychological in origin). The findings are published in the October 4, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

5 Oct 2010

CPS recommends all Canadian babies should be vaccinated against rotavirus

All Canadian babies should be vaccinated against rotavirus, according to a new statement by the Canadian Paediatric Society. The CPS is also calling for public funding of the vaccine, which is not currently covered by provincial or territorial health plans.

5 Oct 2010

U.S. Social Security Administration selects Accenture to implement emerging technology applications

The U.S. Social Security Administration (SSA) has selected Accenture as a prime contractor under the Information Technology Support Services Contract (ITSSC) that will be used to acquire a wide range of IT systems development and modernization services. The ITSSC includes a one-year base period plus six additional one-year options with an aggregate ceiling valued at $2.8 billion.

5 Oct 2010

FDA approves Food Contact Notification for CDG Solution 3000

The FDA notified CDG Environmental, LLC on September 29th of its approval of Food Contact Notification FCN 001011 for CDG Solution 3000 effective October 28, 2010.

5 Oct 2010

AmeriCares, AstraZeneca enter commitment to expand breast cancer treatment in Cambodia

AmeriCares and AstraZeneca Pharmaceuticals have made a three-year commitment to expand early breast cancer detection and treatment in Cambodia in hopes of increasing survival rates.

5 Oct 2010

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.

5 Oct 2010

American Anesthesiology acquires Southeast Anesthesiology Consultants

American Anesthesiology, a subsidiary of MEDNAX, Inc., today announced the acquisition of Southeast Anesthesiology Consultants, P.A., a physician group practice that provides anesthesia care and pain management services at nine hospitals, 12 ambulatory surgery centers and 10 pain management centers principally located in the Charlotte, NC, metropolitan area.

5 Oct 2010

Celldex Therapeutics presents initial clinical data on CDX-1401 cancer vaccine candidate at iSBTc meeting

Celldex Therapeutics, Inc. today announced that the Company presented initial clinical data on CDX-1401 at the 25th Annual Meeting of the International Society of Biological Therapy of Cancer (iSBTc) in Washington, DC. CDX-1401 is a novel antibody-based targeted cancer vaccine candidate being evaluated as a treatment for patients with melanoma and other cancers that are known to express the tumor antigen NY-ESO-1.

5 Oct 2010

Elsevier launches new journal on neuroscience

Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Developmental Cognitive Neuroscience.

5 Oct 2010

Delta Health introduces ClinicalVirtuoso solution to optimize homecare therapist

In response to the growing homecare and therapy markets, and the importance of "aging-in-place" as an alternative solution to institutionalized care, Delta Health Technologies, LLC today announced the introduction of ClinicalVirtuoso the first clinical solution developed to optimize the homecare therapist.

5 Oct 2010

Medical News

Researchers discover therapy for treating terminal stages of cancer

New bill aims to promote federal agency collaboration on foreign aid, national security

Osseon receives second patent NOA for spinal vertebral compression fracture technology

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Media examines PEPFAR hearing, calls for more HIV funding ahead of Global Fund replenishment meeting

Human growth hormone can treat cystic fibrosis symptoms

Researchers identify new type of cell that protects from immune system attack

CrystalGenomics to present Phase I MAD study data at Arrowhead Summit

African leaders to meet in Zambia to discuss country responses to HIV/AIDS

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

CPS recommends all Canadian babies should be vaccinated against rotavirus

U.S. Social Security Administration selects Accenture to implement emerging technology applications

FDA approves Food Contact Notification for CDG Solution 3000

AmeriCares, AstraZeneca enter commitment to expand breast cancer treatment in Cambodia

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

American Anesthesiology acquires Southeast Anesthesiology Consultants

Celldex Therapeutics presents initial clinical data on CDX-1401 cancer vaccine candidate at iSBTc meeting

Elsevier launches new journal on neuroscience

Delta Health introduces ClinicalVirtuoso solution to optimize homecare therapist

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News